CATALYST_TYPE
saveCRL (Complete Response Letter)
FDA letter declining approval and identifying deficiencies.
also known as: crl, complete response letter
🐶 often sniffed alongside
top 4drugs
0
catalysts
0
news
165
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- STAT+: FDA discloses reasons for rejecting Summit drugstat · 1d ago
- FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSKbiopharma dive · 1d ago
- Summit’s rejection letter reveals FDA’s deeper concerns about trial design, safetybiospace · 1d ago
- FDA’s complete response letter for Summit’s ivonescimab cites China-heavy data beyond survival missfiercebiotech · 2d ago
- FDA’s Summit rejection puts PD-1xVEGF class on notice to establish overall survivalbiospace · 3d ago
- Summit's PD-1xVEGF rejected by FDA in lung cancerbiospace · 4d ago
- FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF classfiercebiotech · 6d ago
- FDA appears to pause controversial speedy review program, complete response letter disclosuresfiercebiotech · 7d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that